KORU Medical Systems Inc
For the period ended Dec 31, 2024. Filed Mar 12, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 12, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Power of Attorney
KNOW ALL PERSONS BY THESE PRESENT, that each person whose signature appears below constitutes and appoints Linda Tharby and Thomas Adams, and each of them, acting individually, as her or his attorney-in-fact, each with full power of substitution and resubstitution, for her or him and in her or his name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith and about the premises, as fully to all intents and purposes as she or he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or her or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Linda Tharby Linda Tharby | President, Chief Executive Officer, Director (Principal Executive Officer) | March 12, 2025 |
| /s/ Thomas Adams Thomas Adams | Chief Financial Officer and Treasurer (Principal Financial Officer and Principal Accounting Officer) | March 12, 2025 |
| /s/ R. John Fletcher R. John Fletcher | Chairman of the Board and Director | March 12, 2025 |
| /s/ Edward Wholihan Edward Wholihan | Director | March 12, 2025 |
| /s/ Robert A. Casella Robert A. Casella | Director | March 12, 2025 |
| /s/ Joseph M. Manko, Jr. Joseph M. Manko, Jr. | Director | March 12, 2025 |
| /s/ Shahriar Matin Shahriar Matin | Director | March 12, 2025 |
| /s/ Donna French Donna French | Director | March 12, 2025 |
- 54 -
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.